Company intelligence / Profile preview

Convatec

London, United Kingdomconvatecgroup.com ↗

Ownership: Public · CTEC
Employees: ~10000
Development stage: Commercial

Overview

Convatec's products are commercialized globally and widely adopted in clinical practice. The company focuses on innovation within its core categories—advanced wound care dressings/devices and ostomy/continence/infusion solutions—with ongoing R&D investment to launch new products. Clinical results are typically published for individual devices/dressings showing improved patient outcomes such as infection prevention and skin protection; however, the company does not run traditional pharmaceutical clinical trials.

Therapeutic areas: GastroenterologyNeurologyEndocrinologyDermatology
Modalities: DeviceBiologicHydrogel-based drug delivery therapyPolymer-drug conjugate therapySmall molecule
Industry: Consumable Medical Devices

Financials

Market cap: $26.3M
Enterprise value: $26.3M

Beyond the preview

Go deeper on Convatec.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Convatec.

Explore the full profile